← Eichor
Study identifier: NCT03356132 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants

Condition: Breast Implant; Complications · Quality of Life · Satisfaction  ·  Sponsor: Silimed Industria de Implantes Ltda

PhaseN/A
Planned participants632
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersYes

About this study

The study investigates the safety and performance of Silimed® silicone gel breast implants with a textured surface and Silimed® silicone gel breast implants with polyurethane coated surface. Female patients who underwent primary or secondary breast augmentation using Silimed® breast implants will be followed-up through 10 years. The safety of each type of Silimed® breast implant is going to be assessed by estimating the known and unexpected short- and long-term risk / adverse event rates. The performance of each type of Silimed® breast implant is going to be assesses by estimating the satisfaction and quality of life after implantation.

This description comes directly from the study's public registry record.

Talk to the study team

Ludmila C Donato  ·  +552198399-0573  ·  pesquisaclinica@silimed.com.br

Maria Clara M Sodré  ·  +55212784-2764  ·  pesquisaclinica@silimed.com.br

Always discuss trial participation with your own doctor first.

Locations (1)

Perfektua Serviços Médicos LtdaNiterói, Rio de Janeiro, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03356132